Found: 9
Select item for more details and to access through your institution.
Evaluation and identification of factors related to and gene mutations in colorectal cancer: A meta-analysis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Efficacy of Pyrotinib in HER2-Overexpressing Salivary Duct Carcinoma With Lung Metastasis: A Case Report.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.559057
- By:
- Publication type:
- Article
A Novel Oncogenic Driver in a Lung Adenocarcinoma Patient Harboring an EGFR -KDD and Response to Afatinib.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. 1, doi. 10.3389/fonc.2020.00867
- By:
- Publication type:
- Article
Real‐world efficacy and potential mechanism of resistance of icotinib in Asian advanced non‐small cell lung cancer with EGFR uncommon mutations: A multi‐center study.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 1, p. 12, doi. 10.1002/cam4.2652
- By:
- Publication type:
- Article
Patient harboring a novel PIK3CA point mutation after acquired resistance to crizotinib in an adenocarcinoma with ROS1 rearrangement: A case report and literature review.
- Published in:
- Thoracic Cancer, 2017, v. 8, n. 6, p. 714, doi. 10.1111/1759-7714.12496
- By:
- Publication type:
- Article
Comparison of the c-MET gene amplification between primary tumor and metastatic lymph nodes in non-small cell lung cancer.
- Published in:
- Thoracic Cancer, 2017, v. 8, n. 5, p. 417, doi. 10.1111/1759-7714.12455
- By:
- Publication type:
- Article
Patients harboring ALK rearrangement adenocarcinoma after acquired resistance to crizotinib and transformation to small-cell lung cancer: a case report.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Detection of Her-2/neu expression in gastric cancer: Quantitative PCR versus immunohistochemistry.
- Published in:
- Experimental & Therapeutic Medicine, 2014, v. 8, n. 5, p. 1501, doi. 10.3892/etm.2014.1982
- By:
- Publication type:
- Article
Potential mechanism of primary resistance to icotinib in patients with advanced non–small cell lung cancer harboring uncommon mutant epidermal growth factor receptor: A multi‐center study.
- Published in:
- Cancer Science, 2020, v. 111, n. 2, p. 679, doi. 10.1111/cas.14277
- By:
- Publication type:
- Article